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was estimated using a dedicated software. Correlation 
between OCT-derived protrusion and ESS distribution was 
assessed for both scaffold groups. A significant difference 
was observed in the protrusion distances (156 ± 137 µm for 
Absorb, 139 ± 153 µm for Mirage; p = 0.035), whereas dif-
ference remained after adjusting the protrusion distances 
according to the luminal areas. Strut protrusion of Absorb 
is inversely correlated with ESS (r = −0.369, p < 0.0001), 
whereas in Mirage protrusion was positively correlated 
with EES (r = 0.192, p < 0.0001). Protrusion distance was 
higher in Absorb than in Mirage. The protrusion of the 
thick quadratic struts of Absorb has a tendency to lower 
shear stress in the close vicinity of struts. However, circu-
lar shape of the less thick struts of Mirage didn’t show this 
trend in creating zone of recirculation around the struts. 
Strut geometry has different effect on the relationship 
between protrusion and shear stress in Absorb and Mirage 
scaffolds.
Keywords Protrusion · Strut geometry · Shear stress · 
Bioresorbable scaffold
Introduction
A permanent metallic stent constitutes a foreign structure 
in the vessel wall that induces inflammatory reactions 
increasing the thrombosis risk at post-implantation follow 
up [1]. Bioresorbable scaffolds (BRS) have been intro-
duced to address the disadvantages of metallic drug-eluting 
stents (DES) [2]. Despite its potential long term superiori-
ties, BRS implantation requires some indispensable rules 
for the attention of good stent result at short and long term 
follow up [3]. Embedment of the stent/scaffold is one of 
the surrogate factor affecting the vessel wall reaction after 
Abstract Protrusion of scaffold struts is related with 
local coronary flow dynamics that can promote scaffold 
restenosis and thrombosis. That fact has prompted us to 
investigate in  vivo the protrusion status of different types 
of scaffolds and their relationship with endothelial shear 
stress (ESS) distributions. Six Absorb everolimus-eluting 
Bioresorbable Vascular Scaffolds (Absorb, Abbott Vascu-
lar) and 11 Mirage sirolimus-eluting Bioresorbable Micro-
fiber Scaffolds (Mirage, Manli Cardiology) were implanted 
in coronaries of eight mini pigs. Optical coherence tomog-
raphy (OCT) was performed post-scaffold implantation 
and obtained images were fused with angiographic data 
to reconstruct the three dimensional coronary anatomy. 
Blood flow simulation was performed and ESS distribu-
tion was estimated for each scaffold. Protrusion distance 
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implantation [4]. In metallic stents, the vessel wall stretch 
and injury have been shown to be related with the embed-
ment status of the device [5, 6]. Not only the embedment, 
but also the strut protrusion and related local coronary flow 
hemodynamics, particularly endothelial shear stress (ESS) 
influence biological response of the vessel wall [7, 8]. 
Observational atherosclerosis studies have proposed that 
low ESS promotes atherosclerotic plaque growth in native 
vessel segments [9, 10] and neointimal hyperplasia in scaf-
folded segments after percutaneous coronary intervention 
(PCI) [8].
Optical coherence tomography (OCT) provides high 
resolution data and detailed insights compared to the intra-
vascular ultrasound [11]. OCT-based computational fluid 
dynamic (CFD) studies enable to unravel the effects of 
stent/scaffold design on the local coronary flow behaviors 
at the strut levels [12]. We investigated the relationship 
between struts protrusion and local shear stress distribu-




Eight Yucatan mini pigs with healthy coronaries under-
went PCI in the three epicardial coronary arteries through 
the femoral access according to the standard procedures 
[13]. Six coronary arteries were implanted with a single 
Absorb everolimus-eluting Bioresorbable Vascular Scaf-
folds (Absorb BVS, Abbott Vascular), six coronaries with 
a Mirage sirolimus-eluting Bioresorbable Microfiber 
Scaffold (Mirage BRMS, Manli Cardiology) with 150 
micron (µm) strut thickness (Mirage-150) and five cor-
onary arteries with a Mirage BRMS with 125  µm strut 
thickness (Mirage-125). The protocol approval for the 
animal study was received from the Institutional Animal 
Care and Use Committee. The study was conducted in 
accordance to the American Heart Association guidelines 
for preclinical research and the Guide for the Care and 
Use of Laboratory Animals [14].
Device description
Absorb BVS is composed of polymer backbone of poly 
l-lactic acid (PLLA), coated with a layer of a 1:1 mixture 
of poly d, l-lactic acid (PDLLA) eluting an anti-prolif-
erative drug, everolimus (100 µ/cm2). Polymer tubes are 
extruded into thick-walled, small diameter tubes followed 
by laser cutting [15]. Absorb BVS has 157 µm strut thick-
ness and design of in-phase zig-zag hoops linked with 
bridges (Fig. 1).
Mirage BRMS is made of PDLLA of which d (dex-
tro-rotary)-isomer constitutes <5% of the total polylactic 
acid (PLA), coated with a biodegradable PLA delivering 
sirolimus. In the manufacturing process of Mirage scaf-
fold, the polylactide monofilaments are winded and the 
helix-coiled structures are attached by longitudinal spine 
microfibers (Fig.  1). The struts of Mirage have circular 
shape with thickness of 125  µm in scaffolds with diam-
eter ≤3 mm (Mirage-125), and 150 µm in scaffolds with 
diameter ≥3.5  mm (Mirage-150). The helicoidal design 
is tightened by longitudinal spine microfibers providing 
radial strength for the Mirage (148.54 kPa) comparable to 
the Absorb (148.00 kPa) [16].
Fig. 1  Absorb BVS 1.1 and the 
cross-section of Absorb BVS 
strut (a). Mirage BRMS and the 
cross-section of Mirage BRMS 
strut (b). While the struts of 
Absorb are translucent (c), in 
Mirage the struts are opaque (d) 
in OCT
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Data acquisition
Beside coronary angiography, OCT imaging was imple-
mented after scaffold implantations in all the treated coro-
nary arteries. The treated coronary arteries were evaluated 
with a frequency-domain OCT system (C8-XR OCT Intra-
vascular Imaging System; St. Jude Medical, St. Paul, MN, 
USA) with a pull-back speed of 18 mm/s. A non-occlusive 
flushing technique was utilized by injection of the contrast 
media for blood clearance. The OCT analysis was per-
formed in the scaffolded segment at every 100 µm and in 
the non-scaffolded segments at every 400 µm longitudinal 
intervals.
Coronary angiograms were analyzed with a semi-auto-
mated edge contour detection computer analysis system 
(CAAS QCA-2D system, Pie Medical Imaging BV, Maas-
tricht, The Netherlands) with the dye-filled catheter used 
for calibration following the procedure. In each scaffold, 
the largest balloon diameter and maximal inflation pressure 
during post-dilatation were recorded and used to calculate 
the balloon/artery ratio (mean inflated balloon diameter/
mean reference vessel diameter).
Protrusion analysis by optical coherence tomography
For protrusion analysis, the protrusion distances were esti-
mated semi-automatically using a special version of QCU-
CMS software (version 4.69, Leiden University Medical 
Center, Leiden, The Netherlands) [17] (Fig. 2). The protru-
sion analysis in OCT was performed in the scaffolded seg-
ment at every 200 µm longitudinal interval using a meth-
odology presented previously [17]. The luminal borders of 
both scaffold types and each Absorb BVS strut was auto-
matically detected by the software. Since the QCU-CMS 
has no automatic detection function for the circular struts 
of Mirage BRMS, the struts of the Mirage were depicted 
as part of the lumen contours. Secondarily, the interpola-
tion of the true lumen contour allows an interpolation 
that detects the protrusion of the Mirage struts. In Absorb 
and Mirage groups, struts located at a side branch ostium 
were excluded from the protrusion analysis. Since, at 
hinge points the maximum width of the strut in Absorb is 
800 µm, the struts with >800 µm in Mirage were excluded 
from the protrusion analysis [4].
For the assessment of the intra- and inter-observer repro-
ducibility, two analysts (Observer-A, ET, and observer-B, 
YM) performed OCT protrusion analysis. For the intra-
observer reproducibility, observer-A repeated the measure-
ments on the same pullback for 100 struts after an interval 
of 4-weeks. For the inter-observer reproducibility, the anal-
ysis was repeated in 100 struts by observer-B.
Coronary artery reconstruction
Coronary artery reconstruction was implemented using 
a validated methodology [18]. In X-ray angiographic and 
Fig. 2  Rectangular shaped struts of Absorb BVS (A1) was auto-
matically detected by QCU-CMS (v.14.9) after automatic detection of 
luminal contour (red contour) (A2) and interpolated luminal contour 
(blue contour) (A3), protrusion/embedment distances were detected 
using the methodology described by Sotomi et  al. [20] (A3). The 
illustration (A4) demonstrates the protrusion distance (a), embedment 
depth (b), interpolated luminal contour (c) and embedment line (d). 
The adluminal surface of the circular struts of Mirage BRMS (B1) 
were detected during automatic detection of luminal contour (red) 
(B2). After automatic detection of interpolated luminal contour (blue 
contour) (B3) protrusion distances were measured automatically by 
the software (B3). The illustration (B4) demonstrates the protrusion 
distance (a), embedment depth (b), interpolated luminal contour (c) 
and embedment line (d)
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OCT images, the radiopaque markers and the anatomical 
landmarks (i.e. side branches), identified both on angiog-
raphy and on OCT, were used to define the scaffolded seg-
ment and proximal–distal native vessel segments. In the 
region of interest (ROI), the OCT images depicting the 
scaffolded and the proximal–distal native vessel segments 
were identified and analyzed at a 0.1  mm interval in the 
scaffolded segment and 0.4 mm interval in the native ves-
sel segments. The flow area was delineated and defined in 
the native segments by the luminal border and in the scaf-
folded segments by the adluminal side of the struts and by 
the luminal surface borders between the struts.
Two post-procedure end-diastolic angiographic images 
with at least 30º-angle difference illustrating the ROI with 
minimal foreshortening were selected with the table in the 
isocenter. In these images, the luminal borders were por-
trayed for the ROI and used to extract the luminal center-
line which was then used for the three-dimensional (3D) 
luminal centerline of the ROI [18]. The borders of flow 
area identified on OCT images were then mounted per-
pendicularly onto the luminal centerline and side-branches 
seen in both OCT and angiographic images were utilized to 
establish the absolute orientation of the OCT frames [18].
Computational flow dynamic study
The reconstructed images were processed with CFD tech-
niques. A finite volume mesh was generated and then blood 
flow simulation was performed. ESS was estimated by 
solving the 3D Navier–Stokes equations (ANSYS Fluent, 
Canonsburg, Pennsylvania) [7]. To assess the effect of scaf-
fold designs on the local hemodynamic micro-environment, 
the mesh density around the struts and within the bound-
ary layer of the flow field between the struts was increased 
to have an average element edge of 30 μm (equal to 1/4 of 
the strut thickness). Blood was assumed to be a homogene-
ous, Newtonian fluid with a viscosity of 0.0035  Pa.s and 
a density of 1050 kg/m3. A steady flow profile was simu-
lated at the inflow of the 3D models. Blood flow for each 
reconstruction was estimated by measuring, in the two 
angiographic projections, the number of frames required 
for the contrast agent to pass from the inlet to the outlet of 
the reconstructed segment, the volume of the reconstructed 
segment and the cine frame rate [7]. The arterial wall was 
considered to be rigid. No-slip conditions were imposed at 
the scaffold surface. At the outlet of the model zero pres-
sure conditions were imposed. ESS at luminal surface was 
calculated as the product of blood viscosity and the gradi-
ent of blood velocity at the wall [9]. The ESS was measured 
in the native and the scaffolded segment around the circum-
ference of the lumen per 5° interval (sector) and along the 
axial direction per 0.2 mm interval with the use of an in-
house algorithm [9]. The recirculation zones in the vicinity 
of the struts were quantified based on the direction of the 
ESS vector and the centerline vector. Areas where the ESS 
vector had opposite direction to the centerline vector were 
considered to be exposed to recirculation zones. Recircula-
tion zone percentage was calculated as the vessel luminal 
surface exposed to recirculation divided by in-device vessel 
luminal surface area.
Statistical analysis
Data are expressed as mean ± standard deviation or median 
and inter-quartile range. Normality of distribution was 
tested by the Kolmogorov–Smirnov test. Group means 
for continuous variables with normal and non-normal 
distributions were compared using Student’s t tests and 
Mann–Whitney U tests, respectively. Categorical variables 
were compared using the Pearson’s Chi square test or Fis-
cher’s exact test, as appropriate. Mixed linear model was 
used for the comparisons of continuous variables to take 
into account the clustered nature of >1 scaffolds analyzed 
from the same animals, >1 cross-sections from the same 
scaffolds and >1 struts from the same cross-sections, which 
might result in unknown correlations among measurements 
within the clusters. The protrusion heights were analysed at 
cross-section level and device level for each scaffold type.
Reproducibility of protrusion/embedment analysis for 
Absorb was previously reported by Sotomi et  al. [17]. In 
the present study, reproducibility of the protrusion analy-
sis for Mirage and Absorb were assessed with the interclass 
correlation coefficient (ICC) for absolute agreement (ICCa) 
with its 95% confidence intervals (CI) using randomly 
selected 100 Mirage and 100 Absorb struts. An ICC < 0.4 
indicates bad agreement, an ICC between 0.4 and 0.75 indi-
cates moderate agreement, and ICC values >0.75 indicates 
good agreement [17]. Analyses were performed using the 
statistical analysis program SPSS V.23 (SPSS Inc., Chi-
cago, IL).
Results
One left anterior descending coronary artery (LAD), 
three left circumflex coronary arteries (LCx) and two 
right coronary arteries (RCA) were implanted with an 
Absorb. In Mirage-150 group, 2 LAD, 1 LCX and 3 RCA, 
in Mirage-125 group, 2 LAD, 1 LCX and 2 RCA were 
treated. Procedural characteristics are shown in Table  1. 
Device length was shorter and expected maximum device 
diameter was larger in Mirage than in Absorb. Although 
maximum post-dilatation balloon pressure was significantly 
higher in Mirage, the expected diameter of post-dilatation 
balloon was comparable in both arms. In QCA, balloon/
artery ratio (1.09 ± 0.048 for Absorb vs. 1.13 ± 0.10 for 
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Mirage; p = 0.32) and acute percent recoil (3.15 ± 1.15% for 
Absorb vs. 2.56 ± 2.92% for Mirage; p = 0.65) were compa-
rable between the scaffold groups.
OCT results are summarized in Table  2. The analyses 
were performed at cross-section level (n = 1306) and device 
level (n = 17). In cross-section level analysis, in-device 
Table 1  Procedural details
Scaffold Absorb BVS (n = 6) Mirage BRMS (n = 11) p
Implanted vessel
 LAD/LCx/RCA (n) 1/3/2 4/2/5
Device
 Device nominal size (mm) 3.0 ± 0 3.18 ± 0.37 0.12
 Device length (mm) 17.5 ± 1.22 14.63 ± 0.81 <0.001
 Expected maximum device diameter (mm) 3.05 ± 0.12 3.43 ± 0.42 0.01
 Maximum deployment pressure (atm) 7.0 ± 0 9.82 ± 4.85 0.28
Pre-dilatation
 Pre dilatation performed, n (%) 0 (0%) 0 (0%) 1.00
Post-dilatation
 Post dilatation performed, n (%) 6 (100%) 11 (100%) 1.00
 Post dilatation balloon type
  Semi-compliant balloon, n (%) 0 (0%) 0 (0%)
  Non-compliant balloon, n (%) 6 (100%) 11 (100%) 1.00
 Balloon nominal size (mm) 3.5 ± 0.0 3.57 ± 0.53 0.34
 Maximum post-dilatation balloon pressure (atm) 8.5 ± 2.74 16.36 ± 2.34 0.001
 Maximum expected post-dilatation balloon size (mm) 3.37 ± 0.093 3.65 ± 0.59 0.08
Table 2  OCT analyses results in scaffold groups
Data are expressed as n (%) and mean ± standard deviation
Scaffold Absorb BVS Mirage BRMS p
(n = 6) (n = 11)
Device level
 In-device mean lumen area  (mm2) 7.77 ± 0.70 9.34 ± 2.12 0.081
 Distal reference mean lumen area  (mm2) 5.08 ± 1.31 6.81 ± 1.75 0.038
 Proximal reference mean lumen area  (mm2) 7.46 ± 2.63 6.92 ± 1.71 0.588
 Mean scaffold area  (mm2) 8.09 ± 0.63 9.40 ± 2.07 0.129
 Mean ESS (Pa) 0.73 ± 0.25 0.93 ± 0.24 0.145
 Embedment distance (µm) 22.4 ± 12.8 17.2 ± 13.1 0.43
  Protrusion distance (µm) 156 ± 19 139 ± 21 0.035
 Protrusion distance/mean lumen diameter 0.05 ± 0.40 0.04 ± 0.47 <0.0001
Absorb BVS Mirage BRMS p
(n = 636) (n = 670)
Cross-section level
 In-device mean lumen area  (mm2) 7.62 ± 1.10 9.07 ± 2.26 0.032
 Distal reference mean lumen area  (mm2) 4.74 ± 1.42 6.69 ± 1.95 0.028
 Proximal reference mean lumen area  (mm2) 6.85 ± 2.20 6.77 ± 1.93 0.67
 Mean scaffold area  (mm2) 8.00 ± 0.59 9.17 ± 2.0 0.063
 Mean ESS (Pa) 0.73 ± 2.19 0.93 ± 1.83 0.142
 Embedment distance (µm) 22 ± 37 17 ± 33 0.45
 Protrusion distance (µm) 156 ± 137 139 ± 153 0.035
 Protrusion distance/mean lumen diameter 0.05 ± 0.0038 0.04 ± 0.0034 <0.0001
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mean luminal area was significantly larger in Mirage than 
in Absorb (9.07 ± 2.26 vs. 7.62 ± 1.10  mm2; p = 0.032). 
The mean scaffold area was not significantly differ-
ent between the study arms (8.00 ± 0.59  mm2 for Absorb 
BVS vs. 9.17 ± 2.00  mm2 for Mirage BRMS; p = 0.063). 
The mean ESS values were comparable between Absorb 
and Mirage at cross-section-level analyses (0.73 ± 2.19 vs. 
0.93 ± 1.83 Pa, respectively; p = 0.142).
In the device level analysis, in-device mean lumen area 
was comparable between the scaffolds (7.77 ± 0.70  mm2 
for Absorb vs. 9.34 ± 2.12  mm2 for Mirage; p = 0.081). 
Mean ESS was found comparable between Absorb 
(0.73 ± 0.25  Pa) and Mirage (0.93 ± 0.24  Pa) (p = 0.145). 
In Absorb (n = 6), 75.8 ± 13.0% and in Mirage (n = 11), 
62.7 ± 17.6% of the scaffolded surface was exposed to a 
low (<1 Pa) athero-promoting ESS environment (p = 0.11).
Although numerically less percentage of recircula-
tion area was estimated in Mirage (2.84 ± 1.61%) than in 
Absorb (3.26 ± 2.07%), the difference didn’t reach to statis-
tical significance (p = 0.65).
Protrusion analyses
There were 4591 struts in 477 cross-sections from Absorb 
and 3314 struts in 593 cross-sections from Mirage 
recruited into the protrusion analysis. There were 128 
and 97 malapposed struts in Absorb and Mirage, respec-
tively. In cross-section level analysis, mean protrusion 
distances were significantly different between the scaf-
fold groups [156 ± 137  µm for Absorb, 98.97 ± 16.47% of 
the strut thickness in Absorb, 139 ± 153  µm for Mirage 
(95.63 ± 14.48% of the strut thickness in Mirage-150, 
89.52 ± 17.09% of the strut thickness in Mirage-125); 
p = 0.035]. After adjusting the protrusion distances accord-
ing to the luminal cross-section area, the difference in pro-
trusion distances remained significant (0.050 ± 0.038 for 
Absorb vs. 0.041 ± 0.034 for Mirage; p < 0.0001).
Mean shear stress levels were inversely correlated with 
protrusion distances in Absorb (r = −0.369, p < 0.0001), 
whereas in Mirage, the correlation was in positive direc-
tion (r = 0.192, p < 0.0001) (Fig.  3). The same trend was 
observed with the adjusted protrusion distances; mean 
shear stress values were in negative correlation with the 
adjusted protrusion distances in Absorb (r = −0.420, 
p < 0.0001) and positively correlated with the adjusted pro-
trusion distances in Mirage (r = 0.116, p = 0.005) (Fig. 3).
The inter-observer [ICCa: 0.884 CI (0.827–0.922)] 
and the intra-observer reproducibility [ICCa: 0.782 CI 
(0.675–0.854)] for the protrusion distances indicated 
good agreements in Mirage. In Absorb, the protrusion 
distances demonstrated well inter-observer [ICCa: 0.942 
CI (0.927–0.957)] and intra-observer [ICCa: 0.968 CI 
(0.964–0.972)] reproducibility.
Discussion
In the present study, we investigated the protrusion status 
of two different types of BRS and the effects of protrusion 
on the local hemodynamic microenvironment. The find-
ings can be summarized as follows; (1) the strut protrusion 
distance was lower in Mirage compared to the Absorb; (2) 
mean ESS was comparable between Absorb and Mirage 
scaffolds, (3) in Mirage, ESS had a positive correlation 
with strut protrusion, while in Absorb, ESS was inversely 
correlated with strut protrusion distance.
Scaffold implantation process represents a “double-
edged sword”; the struts should be embedded well enough 
Fig. 3  Mean shear stress values were inversely correlated with pro-
trusion distances in Absorb BVS. However, in Mirage BRMS, shear 
stress values were positively correlated with protrusion distances 
(a). Mean shear stress values were in negative correlation with the 
adjusted strut protrusion distances in Absorb BVS. In Mirage BRMS, 
mean shear stress was positively correlated with adjusted protrusion 
distances (b)
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to prevent flow separation due to the protruded obstacles 
in the new constituted vessel surface. There is however 
an increased risk of vessel wall stretch and injury in case 
of deep embedment [4]. The balance should be respected 
meticulously during the implantation process to avoid from 
both vessel wall injury and increment in flow disruption.
Relationship between ESS and protrusion
Absorb appears to disrupt the coronary flow due to its 
thicker rectangular struts and high protrusion distances in 
the coronary lumen. Mirage, albeit lack of statistical sig-
nificance, with its circular thinner struts, induced less flow 
separations which could be explained with the thinner 
streamlined strut cross-profile and the helicoidal design of 
the scaffold [19, 20]. Mean shear stress levels were found 
comparable between the scaffold groups. Despite weak cor-
relation coefficients, ESS has a tendency to decrease with 
the protrusion distance in Absorb, while in Mirage shear 
stress is inversely proportional to the protrusion distance. 
This discrepancy in the relation between the protrusion and 
ESS in the scaffolds can be explained with the confounding 
factor of different strut shapes in the scaffolds. In Absorb, 
the non-streamlined thicker strut profile disrupts the lami-
nar flow inducing lower shear stress around the rectangu-
lar struts due to the recirculation and stagnation zones [20]. 
The shear stress on top of the rectangular struts in Absorb 
is higher than the shear stress at upstream and downstream 
sides of the struts (Fig.  4). But the non-linear increase in 
flow disruption around the rectangular struts and related 
lower ESS levels should have dominated for the relation 
between ESS and protrusion distance in Absorb [20].
In Mirage, ESS was in positive relation with the strut 
protrusion which seems to be a paradox. However, reduced 
flow disruption due to the circular strut geometry and the 
gradual changes in the slope over the strut surface reversed 
the relation of ESS with strut protrusion [19, 20]. With the 
same protruded distances, circular geometries induce less 
flow disruptions and lower flow separation distances which 
provide less low shear values around the circular struts [20, 
21]. Additionally, according to the Bernoulli principle, the 
flow accelerates over a streamlined geometry which may 
Fig. 4  The shear stress distri-
bution in a cross-section from 
Absorb (a) and Mirage (b). In 
Absorb, low shear stress zones 
can be seen between the struts 
wider than in Mirage. Despite 
comparable strut thicknesses in 
Absorb (157 µm) and Mirage 
(150 µm) the low shear stress 
zones (dark blue areas) are 
much less in Mirage scaffolds 
than in Absorb
Fig. 5  The shear stress distributions of each scaffold in carpet view. 
Circular struts demonstrate better performance than quadratic geom-
etries in terms of shear stress distribution. The zones of shear stress 
within physiologic ranges seen more frequently in Mirage-150 than in 
Absorb BVS, despite comparable strut thicknesses
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also help to explain the positive relation of shear stress 
with protrusion distance in Mirage. Accelerated flow veloc-
ity over the circular struts increases shear stress not only 
at the top surface but also at the upstream and downstream 
sides of the circular struts as the protrusion rises [22, 23] 
(Fig. 4). In similar strut thicknesses, circular designs dem-
onstrate better performance in terms of shear stress levels 
[24]. The shear stress distribution from the present study 
confirms this point. In scaffolds with comparable strut 
thicknesses, the shear stress distributions unraveled more 
physiologic shear stress levels in Mirage-150 group than in 
Absorb (Fig. 5).
The scaffolds with similar strut profile with Absorb BVS 
such as DREAMS 2G and DESolve, have comparable strut 
thicknesses (DREAMS 2G: 150 µm [25], DESolve: 150 µm 
[16]). Beside the strut thickness, the width of the strut is 
also another factor in penetration of the strut into the ves-
sel wall during the implantation process [26, 27]. While 
the width of the struts in Absorb is around 191 µm in the 
hoops, the struts of DREAMS and DESolve scaffolds have 
widths of 140 and 165  µm, which means that narrower 
struts can penetrate into the vessel wall deeper that corre-
sponds to less protrusion and less flow disturbance. CFD 
modelings can be used to modify the strut design to reach 
more hemocompatible geometries.
Flow-disruption and decreased shear stress levels in 
the vicinity of the struts increase a tendency to thrombus 
formation which was demonstrated in bench studies [21]. 
Low shear stress has been incriminated for restenosis and 
stent/scaffold thrombosis at post-implantation follow up 
[28]. The flow separations beside the rectangular struts 
promote stagnation zones that create well-suited environ-
ment for thrombus formation. However, even with compa-
rable aspect ratios with the quadratic geometries, the flow 
streamlines slipping over circular struts with less disrup-
tion decrease the risk of fibrin aggregation [21]. The fibrin 
accumulation and thrombus formation may affect the anti-
proliferative drug kinetics. Drug diffusion from the poly-
mer to the vessel wall can be interrupted by cumulated 
fibrin which may impoverish the endothelial lining through 
the accrued drug around the struts. Impaired endothelial 
sealing of the struts can increase re-stenosis risk at follow 
Fig. 6  The histology sec-
tions from Absorb (a, b) 
revealed struts with insufficient 
endothelial coverage (asterisk) 
whereas in Mirage (c, d), struts 
were detected fully covered by 
neointimal tissue
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up [29]. At 30-day follow up, 2 animals from the present 
study sacrificed and underwent histopathological analysis. 
From Absorb (n = 2) and Mirage (n = 2), sections (n = 12) 
from proximal, middle and distal portions of each scaf-
fold were assessed by histopathologists. The fibrin score in 
Absorb (2.5 ± 0.55) was higher than in Mirage (2.17 ± 0.41) 
(p = 0.26) and endothelial coverage rate was lower in 
Absorb (56.5 ± 38.07%) than in Mirage (82.33 ± 18.99%) 
(p = 0.18). However, due to low case number there were no 
statistical differences between the scaffold groups (Fig. 6).
Limitations
A significant limitation of the current analysis is that scaf-
fold implantation was performed in healthy coronary arter-
ies. Therefore, it was not possible to examine the implica-
tions of scaffold under-expansion or the composition of the 
underlying plaque on strut embedment which potentially 
influence the local flow hemodynamics. There were dif-
ferences in the lumen areas in the two groups which are 
likely to affect the ESS values. Nevertheless, the difference 
in ESS was not statistically significant; in addition, in lin-
ear mixed effect analysis scaffold type was independently 
associated with the ESS distribution. There was no clinical 
result for protrusion-ESS relationship in the current study. 
Due to low number of cases (totally 12 histology specimens 
from 4 scaffolds), we didn’t present histopathology results 
at 30-day post-implantation in detail. However, clinical 
inferences can be exemplified from the literature. Finally, 
the protrusion software used for the analysis has been 
established for quadratic struts of Absorb. A well-designed 
software for circular struts may overcome the constrain of 
reproducibility in Mirage scaffolds.
Conclusion
Protrusion has impact on the local hemodynamics in biore-
sorbable scaffolds. Strut geometry has diverse effects on 
the relationship between protrusion distance and shear 
stress in Absorb and Mirage scaffolds. Protrusion analysis 
may contribute to figure out hemodynamic performance of 
the bioresorbable scaffolds.
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